Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Функциональная диспепсия в свете Римских критериев IV пересмотра (2016 г.)
Функциональная диспепсия в свете Римских критериев IV пересмотра (2016 г.)
Маев И.В., Дичева Д.Т., Щегланова М.П. и др. Функциональная диспепсия в свете Римских критериев IV пересмотра (2016 г.). Consilium Medicum. Гастроэнтерология (Прил.). 2016; 2: 5–10.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В обзорной статье отражены современные представления о функциональной диспепсии (ФД), основанные на положениях Римского консенсуса IV пересмотра (2016 г.). Рассмотрены вопросы дефиниции, классификации, этиологии и патогенеза, особенностей клинической картины и критериев диагностики ФД. Представлены актуальные данные о фармакотерапии ФД с позиций доказательной медицины.
Ключевые слова: функциональная диспепсия, Римские критерии IV, диагностика, лечение, итоприд.
Key words: functional dyspepsia, the Rome IV criteria, diagnosis, treatment, itopride.eview article deals with the modern views on functional dyspepsia (FD) based on the 2016 Rome IV diagnostic criteria updates. The authors report the definition, classification, etiology and pathogenesis, clinical findings and diagnostic criteria for FD. The authors present the current characteristics concerning FD pharmacotherapy from the perspective of evidence-based medicine.
Key words: functional dyspepsia, the Rome IV criteria, diagnosis, treatment, itopride.
Ключевые слова: функциональная диспепсия, Римские критерии IV, диагностика, лечение, итоприд.
________________________________________________
Key words: functional dyspepsia, the Rome IV criteria, diagnosis, treatment, itopride.eview article deals with the modern views on functional dyspepsia (FD) based on the 2016 Rome IV diagnostic criteria updates. The authors report the definition, classification, etiology and pathogenesis, clinical findings and diagnostic criteria for FD. The authors present the current characteristics concerning FD pharmacotherapy from the perspective of evidence-based medicine.
Key words: functional dyspepsia, the Rome IV criteria, diagnosis, treatment, itopride.
Полный текст
Список литературы
1. Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology 2016; 150: 1262–79.
2. Stanghellini V, Chan FK, Hasler WL et al Gastroduodenal Disorders. Gastroentero-logy 2016; 150 (6): 1380–92.
3. Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology 2016; 150 (6): 1257–61.
4. Levy RL, Olden KW, Naliboff BD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1447–58.
5. Pasricha PJ. Neurogastroenterology: a great career choice for aspiring gastroenterologists thinking about thefuture. Gastroenterology 2011; 140: 1126–8.
6. Sleisenger and Fordtran's Gastrointestinaland Liver Disease: Pathophysiology, Diagnosis, Management. Edited by Mark Feldman, Lawrence S Friedman, Laurence J Brandt. 10th ed. 2015.
7. Jones MP, Dilley JB, Drossman D et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil 2006; 18: 91–103.
8. Gaman A, Kuo B. Neuromodulatory processes of thebrain-gut axis. Neuromodulation 2008; 11: 249–59.
9. Mittal R, Debs LH, Patel AP et al Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis. J Cell Physiol 2016. DOI: 10.1002/jcp.25518. [Epub ahead of print]
10. Маев И.В., Кучерявый Ю.А., Андреев Д.Н. Функциональная диспепсия: эпидемиология, классификация, этиопатогенез, диагностика и лечение. М., 2015. / Maev I.V., Kucheriavyi Iu.A., Andreev D.N. Funktsional'naia dispepsiia: epidemiologiia, klassifikatsiia, etiopatogenez, diagnostika i lechenie. M., 2015. [in Russian]
11. Vanheel H, Farré R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 142–9.
12. Маев И.В., Андреев Д.Н., Кучерявый Ю.А. и др. Современные представления о патофизиологических основах синдрома функциональной диспепсии. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2015; 4: 15–22. / Maev I.V., Andreev D.N., Kucheriavyi Iu.A. i dr. Sovremennye predstavleniia o patofiziologicheskikh osnovakh sindroma funktsional'noi dispepsii. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2015; 4: 15–22. [in Russian]
13. Rahim MK, Durr-e-Sabih, Mateen A et al. Studies of gastric emptying time in patients with non-ulcer dyspepsia. Nucl Med Commun 2007; 28: 852–8.
14. Maes BD, Ghoos YF, Hiele MI, Rutgeerts PJ. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci 1997; 42 (6): 1158–62.
15. Quartero AO, de Wit NJ, Lodder AC et al. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998; 43 (9): 2028–33.
16. Маев И.В., Самсонов А.А., Андреев Д.Н. Болезни желудка. М.: ГЭОТАР-Медиа, 2015. / Maev I.V., Samsonov A.A., Andreev D.N. Bolezni zheludka. M.: GEOTAR-Media, 2015. [in Russian]
17. Kindt S, Tack J. Impaired gastric accommodation and its role in dyspepsia. Gut 2006; 55 (12): 1685–91.
18. Piessevaux H, Tack J, Walrand S et al. Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms. Neurogastroenterol Motil 2003; 15: 447–55.
19. Vandenberghe J, Vos R, Persoons P et al. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut 2005; 54: 914–9.
20. Tack J, Caenepeel P, Fischler B et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121 (3): 526–35.
21. Mertz H, Fullerton S, Naliboff B, Mayer EA. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998; 42 (6): 814–22.
22. Маев И.В., Самсонов А.А., Андреев Д.Н. Инфекция Helicobacter pylori. М.: ГЭОТАР-Медиа, 2016. / Maev I.V., Samsonov A.A., Andreev D.N. Infektsiia Helicobacter pylori. M.: GEOTAR-Media, 2016. [in Russian]
23. Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005; Is. 2: CD002096.
24. Zhao B, Zhao J, Cheng WF et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol 2014; 48: 241–7.
25. Маев И.В., Андреев Д.Н., Дичева Д.Т. и др. Функциональная диспепсия: современное состояние проблемы. Мед. вест. МВД. 2013; 4: 38–45. / Maev I.V., Andreev D.N., Dicheva D.T. i dr. Funktsional'naia dispepsiia: sovremennoe sostoianie problemy. Med. vest. MVD. 2013; 4: 38–45. [in Russian]
26. Маев И.В., Самсонов А.А., Андреев Д.Н., Кочетов С.А. Дифференцированная тактика лечения синдрома функциональной диспепсии. Мед. совет. 2012; 9: 13–20. / Maev I.V., Samsonov A.A., Andreev D.N., Kochetov S.A. Differentsirovannaia taktika lecheniia sindroma funktsional'noi dispepsii. Med. sovet. 2012; 9: 13–20. [in Russian]
27. Руководство по внутренней медицине. Под ред. Г.П.Арутюнова, А.И.Мартынова, А.А.Спасского. М., 2015. / Rukovodstvo po vnutrennei meditsine. Pod red. G.P.Arutiunova, A.I.Martynova, A.A.Spasskogo. M., 2015. [in Russian]
28. Wang WH, Huang JQ, Zheng GF et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007; 5 (2): 178–85.
29. Маев И.В., Самсонов А.А., Андреев Д.Н. Клиническое значение синдрома «перекреста» функциональной диспепсии и гастроэзофагеальной рефлюксной болезни. Клин. перспективы гастроэнтерологии, гепатологии. 2013; 5: 17–22. / Maev I.V., Samsonov A.A., Andreev D.N. Klinicheskoe znachenie sindroma «perekresta» funktsional'noi dispepsii i gastroezofageal'noi refliuksnoi bolezni. Klin. perspektivy gastroenterologii, gepatologii. 2013; 5: 17–22. [in Russian]
30. Кучерявый Ю.А., Андреев Д.Н. Функциональная диспепсия: современный алгоритм терапии и реалии российской практики. Consilium Medicum. Гастроэнтерология. 2014; 1: 27–32. / Kucheriavyi Iu.A., Andreev D.N. Funktsional'naia dispepsiia: sovremennyi algoritm terapii i realii rossiiskoi praktiki. Consilium Medicum. Gastroenterology (Suppl.). 2014; 1: 27–32. [in Russian]
31. McNicholl AG, Linares PM, Nyssen OP et al. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 2012; 36: 414–25.
32. Moayyedi P, Soo S, Deeks J et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; 4: CD001960.
33. Van Noord C, Dieleman JP, van Herpen G et al. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf 2010; 33 (11): 1003–14.
34. Holtmann G, Talley NJ, Liebregts T et al. A Placebo-Controlled Trial of Itopride in Functional Dyspepsia. NEJM 2006; 23 (354): 832–40.
35. Sun J, Yuan YZ, Holtmann G. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study. Clin Drug Investig 2011; 31 (12): 865–75.
36. Huang X, Lv B, Zhang S et al. Itopride therapy for functional dyspepsia: a meta-analysis. World J Gastroenterol 2012; 18 (48): 7371–7.
37. Ивашкин В.Т., Шептулин А.А., Трухманов А.С. Эффективность применения ганатона (итоприда гидрохлорида) в лечении больных функциональной диспепсией. Фарматека. 2009; 13: 50–4. / Ivashkin V.T., Sheptulin A.A., Trukhmanov A.S. Effektivnost' primeneniia ganatona (itoprida gidrokhlorida) v lechenii bol'nykh funktsional'noi dispepsiei. Farmateka. 2009; 13: 50–4. [in Russian]
2. Stanghellini V, Chan FK, Hasler WL et al Gastroduodenal Disorders. Gastroentero-logy 2016; 150 (6): 1380–92.
3. Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology 2016; 150 (6): 1257–61.
4. Levy RL, Olden KW, Naliboff BD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1447–58.
5. Pasricha PJ. Neurogastroenterology: a great career choice for aspiring gastroenterologists thinking about thefuture. Gastroenterology 2011; 140: 1126–8.
6. Sleisenger and Fordtran's Gastrointestinaland Liver Disease: Pathophysiology, Diagnosis, Management. Edited by Mark Feldman, Lawrence S Friedman, Laurence J Brandt. 10th ed. 2015.
7. Jones MP, Dilley JB, Drossman D et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil 2006; 18: 91–103.
8. Gaman A, Kuo B. Neuromodulatory processes of thebrain-gut axis. Neuromodulation 2008; 11: 249–59.
9. Mittal R, Debs LH, Patel AP et al Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis. J Cell Physiol 2016. DOI: 10.1002/jcp.25518. [Epub ahead of print]
10. Maev I.V., Kucheriavyi Iu.A., Andreev D.N. Funktsional'naia dispepsiia: epidemiologiia, klassifikatsiia, etiopatogenez, diagnostika i lechenie. M., 2015. [in Russian]
11. Vanheel H, Farré R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 142–9.
12. Maev I.V., Andreev D.N., Kucheriavyi Iu.A. i dr. Sovremennye predstavleniia o patofiziologicheskikh osnovakh sindroma funktsional'noi dispepsii. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2015; 4: 15–22. [in Russian]
13. Rahim MK, Durr-e-Sabih, Mateen A et al. Studies of gastric emptying time in patients with non-ulcer dyspepsia. Nucl Med Commun 2007; 28: 852–8.
14. Maes BD, Ghoos YF, Hiele MI, Rutgeerts PJ. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci 1997; 42 (6): 1158–62.
15. Quartero AO, de Wit NJ, Lodder AC et al. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998; 43 (9): 2028–33.
16. Maev I.V., Samsonov A.A., Andreev D.N. Bolezni zheludka. M.: GEOTAR-Media, 2015. [in Russian]
17. Kindt S, Tack J. Impaired gastric accommodation and its role in dyspepsia. Gut 2006; 55 (12): 1685–91.
18. Piessevaux H, Tack J, Walrand S et al. Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms. Neurogastroenterol Motil 2003; 15: 447–55.
19. Vandenberghe J, Vos R, Persoons P et al. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut 2005; 54: 914–9.
20. Tack J, Caenepeel P, Fischler B et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121 (3): 526–35.
21. Mertz H, Fullerton S, Naliboff B, Mayer EA. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998; 42 (6): 814–22.
22. Maev I.V., Samsonov A.A., Andreev D.N. Infektsiia Helicobacter pylori. M.: GEOTAR-Media, 2016. [in Russian]
23. Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005; Is. 2: CD002096.
24. Zhao B, Zhao J, Cheng WF et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol 2014; 48: 241–7.
25. Maev I.V., Andreev D.N., Dicheva D.T. i dr. Funktsional'naia dispepsiia: sovremennoe sostoianie problemy. Med. vest. MVD. 2013; 4: 38–45. [in Russian]
26. Maev I.V., Samsonov A.A., Andreev D.N., Kochetov S.A. Differentsirovannaia taktika lecheniia sindroma funktsional'noi dispepsii. Med. sovet. 2012; 9: 13–20. [in Russian]
27. Rukovodstvo po vnutrennei meditsine. Pod red. G.P.Arutiunova, A.I.Martynova, A.A.Spasskogo. M., 2015. [in Russian]
28. Wang WH, Huang JQ, Zheng GF et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007; 5 (2): 178–85.
29. Maev I.V., Samsonov A.A., Andreev D.N. Klinicheskoe znachenie sindroma «perekresta» funktsional'noi dispepsii i gastroezofageal'noi refliuksnoi bolezni. Klin. perspektivy gastroenterologii, gepatologii. 2013; 5: 17–22. [in Russian]
30. Kucheriavyi Iu.A., Andreev D.N. Funktsional'naia dispepsiia: sovremennyi algoritm terapii i realii rossiiskoi praktiki. Consilium Medicum. Gastroenterology (Suppl.). 2014; 1: 27–32. [in Russian]
31. McNicholl AG, Linares PM, Nyssen OP et al. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 2012; 36: 414–25.
32. Moayyedi P, Soo S, Deeks J et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; 4: CD001960.
33. Van Noord C, Dieleman JP, van Herpen G et al. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf 2010; 33 (11): 1003–14.
34. Holtmann G, Talley NJ, Liebregts T et al. A Placebo-Controlled Trial of Itopride in Functional Dyspepsia. NEJM 2006; 23 (354): 832–40.
35. Sun J, Yuan YZ, Holtmann G. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study. Clin Drug Investig 2011; 31 (12): 865–75.
36. Huang X, Lv B, Zhang S et al. Itopride therapy for functional dyspepsia: a meta-analysis. World J Gastroenterol 2012; 18 (48): 7371–7.
37. Ivashkin V.T., Sheptulin A.A., Trukhmanov A.S. Effektivnost' primeneniia ganatona (itoprida gidrokhlorida) v lechenii bol'nykh funktsional'noi dispepsiei. Farmateka. 2009; 13: 50–4. [in Russian]
2. Stanghellini V, Chan FK, Hasler WL et al Gastroduodenal Disorders. Gastroentero-logy 2016; 150 (6): 1380–92.
3. Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology 2016; 150 (6): 1257–61.
4. Levy RL, Olden KW, Naliboff BD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1447–58.
5. Pasricha PJ. Neurogastroenterology: a great career choice for aspiring gastroenterologists thinking about thefuture. Gastroenterology 2011; 140: 1126–8.
6. Sleisenger and Fordtran's Gastrointestinaland Liver Disease: Pathophysiology, Diagnosis, Management. Edited by Mark Feldman, Lawrence S Friedman, Laurence J Brandt. 10th ed. 2015.
7. Jones MP, Dilley JB, Drossman D et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil 2006; 18: 91–103.
8. Gaman A, Kuo B. Neuromodulatory processes of thebrain-gut axis. Neuromodulation 2008; 11: 249–59.
9. Mittal R, Debs LH, Patel AP et al Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis. J Cell Physiol 2016. DOI: 10.1002/jcp.25518. [Epub ahead of print]
10. Маев И.В., Кучерявый Ю.А., Андреев Д.Н. Функциональная диспепсия: эпидемиология, классификация, этиопатогенез, диагностика и лечение. М., 2015. / Maev I.V., Kucheriavyi Iu.A., Andreev D.N. Funktsional'naia dispepsiia: epidemiologiia, klassifikatsiia, etiopatogenez, diagnostika i lechenie. M., 2015. [in Russian]
11. Vanheel H, Farré R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 142–9.
12. Маев И.В., Андреев Д.Н., Кучерявый Ю.А. и др. Современные представления о патофизиологических основах синдрома функциональной диспепсии. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2015; 4: 15–22. / Maev I.V., Andreev D.N., Kucheriavyi Iu.A. i dr. Sovremennye predstavleniia o patofiziologicheskikh osnovakh sindroma funktsional'noi dispepsii. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2015; 4: 15–22. [in Russian]
13. Rahim MK, Durr-e-Sabih, Mateen A et al. Studies of gastric emptying time in patients with non-ulcer dyspepsia. Nucl Med Commun 2007; 28: 852–8.
14. Maes BD, Ghoos YF, Hiele MI, Rutgeerts PJ. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci 1997; 42 (6): 1158–62.
15. Quartero AO, de Wit NJ, Lodder AC et al. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998; 43 (9): 2028–33.
16. Маев И.В., Самсонов А.А., Андреев Д.Н. Болезни желудка. М.: ГЭОТАР-Медиа, 2015. / Maev I.V., Samsonov A.A., Andreev D.N. Bolezni zheludka. M.: GEOTAR-Media, 2015. [in Russian]
17. Kindt S, Tack J. Impaired gastric accommodation and its role in dyspepsia. Gut 2006; 55 (12): 1685–91.
18. Piessevaux H, Tack J, Walrand S et al. Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms. Neurogastroenterol Motil 2003; 15: 447–55.
19. Vandenberghe J, Vos R, Persoons P et al. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut 2005; 54: 914–9.
20. Tack J, Caenepeel P, Fischler B et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121 (3): 526–35.
21. Mertz H, Fullerton S, Naliboff B, Mayer EA. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998; 42 (6): 814–22.
22. Маев И.В., Самсонов А.А., Андреев Д.Н. Инфекция Helicobacter pylori. М.: ГЭОТАР-Медиа, 2016. / Maev I.V., Samsonov A.A., Andreev D.N. Infektsiia Helicobacter pylori. M.: GEOTAR-Media, 2016. [in Russian]
23. Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005; Is. 2: CD002096.
24. Zhao B, Zhao J, Cheng WF et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol 2014; 48: 241–7.
25. Маев И.В., Андреев Д.Н., Дичева Д.Т. и др. Функциональная диспепсия: современное состояние проблемы. Мед. вест. МВД. 2013; 4: 38–45. / Maev I.V., Andreev D.N., Dicheva D.T. i dr. Funktsional'naia dispepsiia: sovremennoe sostoianie problemy. Med. vest. MVD. 2013; 4: 38–45. [in Russian]
26. Маев И.В., Самсонов А.А., Андреев Д.Н., Кочетов С.А. Дифференцированная тактика лечения синдрома функциональной диспепсии. Мед. совет. 2012; 9: 13–20. / Maev I.V., Samsonov A.A., Andreev D.N., Kochetov S.A. Differentsirovannaia taktika lecheniia sindroma funktsional'noi dispepsii. Med. sovet. 2012; 9: 13–20. [in Russian]
27. Руководство по внутренней медицине. Под ред. Г.П.Арутюнова, А.И.Мартынова, А.А.Спасского. М., 2015. / Rukovodstvo po vnutrennei meditsine. Pod red. G.P.Arutiunova, A.I.Martynova, A.A.Spasskogo. M., 2015. [in Russian]
28. Wang WH, Huang JQ, Zheng GF et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007; 5 (2): 178–85.
29. Маев И.В., Самсонов А.А., Андреев Д.Н. Клиническое значение синдрома «перекреста» функциональной диспепсии и гастроэзофагеальной рефлюксной болезни. Клин. перспективы гастроэнтерологии, гепатологии. 2013; 5: 17–22. / Maev I.V., Samsonov A.A., Andreev D.N. Klinicheskoe znachenie sindroma «perekresta» funktsional'noi dispepsii i gastroezofageal'noi refliuksnoi bolezni. Klin. perspektivy gastroenterologii, gepatologii. 2013; 5: 17–22. [in Russian]
30. Кучерявый Ю.А., Андреев Д.Н. Функциональная диспепсия: современный алгоритм терапии и реалии российской практики. Consilium Medicum. Гастроэнтерология. 2014; 1: 27–32. / Kucheriavyi Iu.A., Andreev D.N. Funktsional'naia dispepsiia: sovremennyi algoritm terapii i realii rossiiskoi praktiki. Consilium Medicum. Gastroenterology (Suppl.). 2014; 1: 27–32. [in Russian]
31. McNicholl AG, Linares PM, Nyssen OP et al. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 2012; 36: 414–25.
32. Moayyedi P, Soo S, Deeks J et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; 4: CD001960.
33. Van Noord C, Dieleman JP, van Herpen G et al. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf 2010; 33 (11): 1003–14.
34. Holtmann G, Talley NJ, Liebregts T et al. A Placebo-Controlled Trial of Itopride in Functional Dyspepsia. NEJM 2006; 23 (354): 832–40.
35. Sun J, Yuan YZ, Holtmann G. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study. Clin Drug Investig 2011; 31 (12): 865–75.
36. Huang X, Lv B, Zhang S et al. Itopride therapy for functional dyspepsia: a meta-analysis. World J Gastroenterol 2012; 18 (48): 7371–7.
37. Ивашкин В.Т., Шептулин А.А., Трухманов А.С. Эффективность применения ганатона (итоприда гидрохлорида) в лечении больных функциональной диспепсией. Фарматека. 2009; 13: 50–4. / Ivashkin V.T., Sheptulin A.A., Trukhmanov A.S. Effektivnost' primeneniia ganatona (itoprida gidrokhlorida) v lechenii bol'nykh funktsional'noi dispepsiei. Farmateka. 2009; 13: 50–4. [in Russian]
________________________________________________
2. Stanghellini V, Chan FK, Hasler WL et al Gastroduodenal Disorders. Gastroentero-logy 2016; 150 (6): 1380–92.
3. Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology 2016; 150 (6): 1257–61.
4. Levy RL, Olden KW, Naliboff BD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1447–58.
5. Pasricha PJ. Neurogastroenterology: a great career choice for aspiring gastroenterologists thinking about thefuture. Gastroenterology 2011; 140: 1126–8.
6. Sleisenger and Fordtran's Gastrointestinaland Liver Disease: Pathophysiology, Diagnosis, Management. Edited by Mark Feldman, Lawrence S Friedman, Laurence J Brandt. 10th ed. 2015.
7. Jones MP, Dilley JB, Drossman D et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil 2006; 18: 91–103.
8. Gaman A, Kuo B. Neuromodulatory processes of thebrain-gut axis. Neuromodulation 2008; 11: 249–59.
9. Mittal R, Debs LH, Patel AP et al Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis. J Cell Physiol 2016. DOI: 10.1002/jcp.25518. [Epub ahead of print]
10. Maev I.V., Kucheriavyi Iu.A., Andreev D.N. Funktsional'naia dispepsiia: epidemiologiia, klassifikatsiia, etiopatogenez, diagnostika i lechenie. M., 2015. [in Russian]
11. Vanheel H, Farré R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 142–9.
12. Maev I.V., Andreev D.N., Kucheriavyi Iu.A. i dr. Sovremennye predstavleniia o patofiziologicheskikh osnovakh sindroma funktsional'noi dispepsii. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2015; 4: 15–22. [in Russian]
13. Rahim MK, Durr-e-Sabih, Mateen A et al. Studies of gastric emptying time in patients with non-ulcer dyspepsia. Nucl Med Commun 2007; 28: 852–8.
14. Maes BD, Ghoos YF, Hiele MI, Rutgeerts PJ. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci 1997; 42 (6): 1158–62.
15. Quartero AO, de Wit NJ, Lodder AC et al. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998; 43 (9): 2028–33.
16. Maev I.V., Samsonov A.A., Andreev D.N. Bolezni zheludka. M.: GEOTAR-Media, 2015. [in Russian]
17. Kindt S, Tack J. Impaired gastric accommodation and its role in dyspepsia. Gut 2006; 55 (12): 1685–91.
18. Piessevaux H, Tack J, Walrand S et al. Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms. Neurogastroenterol Motil 2003; 15: 447–55.
19. Vandenberghe J, Vos R, Persoons P et al. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut 2005; 54: 914–9.
20. Tack J, Caenepeel P, Fischler B et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121 (3): 526–35.
21. Mertz H, Fullerton S, Naliboff B, Mayer EA. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998; 42 (6): 814–22.
22. Maev I.V., Samsonov A.A., Andreev D.N. Infektsiia Helicobacter pylori. M.: GEOTAR-Media, 2016. [in Russian]
23. Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005; Is. 2: CD002096.
24. Zhao B, Zhao J, Cheng WF et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol 2014; 48: 241–7.
25. Maev I.V., Andreev D.N., Dicheva D.T. i dr. Funktsional'naia dispepsiia: sovremennoe sostoianie problemy. Med. vest. MVD. 2013; 4: 38–45. [in Russian]
26. Maev I.V., Samsonov A.A., Andreev D.N., Kochetov S.A. Differentsirovannaia taktika lecheniia sindroma funktsional'noi dispepsii. Med. sovet. 2012; 9: 13–20. [in Russian]
27. Rukovodstvo po vnutrennei meditsine. Pod red. G.P.Arutiunova, A.I.Martynova, A.A.Spasskogo. M., 2015. [in Russian]
28. Wang WH, Huang JQ, Zheng GF et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007; 5 (2): 178–85.
29. Maev I.V., Samsonov A.A., Andreev D.N. Klinicheskoe znachenie sindroma «perekresta» funktsional'noi dispepsii i gastroezofageal'noi refliuksnoi bolezni. Klin. perspektivy gastroenterologii, gepatologii. 2013; 5: 17–22. [in Russian]
30. Kucheriavyi Iu.A., Andreev D.N. Funktsional'naia dispepsiia: sovremennyi algoritm terapii i realii rossiiskoi praktiki. Consilium Medicum. Gastroenterology (Suppl.). 2014; 1: 27–32. [in Russian]
31. McNicholl AG, Linares PM, Nyssen OP et al. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 2012; 36: 414–25.
32. Moayyedi P, Soo S, Deeks J et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; 4: CD001960.
33. Van Noord C, Dieleman JP, van Herpen G et al. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf 2010; 33 (11): 1003–14.
34. Holtmann G, Talley NJ, Liebregts T et al. A Placebo-Controlled Trial of Itopride in Functional Dyspepsia. NEJM 2006; 23 (354): 832–40.
35. Sun J, Yuan YZ, Holtmann G. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study. Clin Drug Investig 2011; 31 (12): 865–75.
36. Huang X, Lv B, Zhang S et al. Itopride therapy for functional dyspepsia: a meta-analysis. World J Gastroenterol 2012; 18 (48): 7371–7.
37. Ivashkin V.T., Sheptulin A.A., Trukhmanov A.S. Effektivnost' primeneniia ganatona (itoprida gidrokhlorida) v lechenii bol'nykh funktsional'noi dispepsiei. Farmateka. 2009; 13: 50–4. [in Russian]
Авторы
И.В.Маев, Д.Т.Дичева, М.П.Щегланова, Д.Н.Андреев*, А.В.Заборовский
ФГБОУ ВО Московский государственный медико-стоматологический университет им. А.И.Евдокимова Минздрава России. 127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1
*dna-mit8@mail.ru
A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation. 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
*dna-mit8@mail.ru
ФГБОУ ВО Московский государственный медико-стоматологический университет им. А.И.Евдокимова Минздрава России. 127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1
*dna-mit8@mail.ru
________________________________________________
A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation. 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
*dna-mit8@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.